申请人:——
公开号:US20030216373A1
公开(公告)日:2003-11-20
Compounds of the formula (I), or a pharmaceutically acceptable salt, or an in-vivo-hydrolysable ester thereof,
1
wherein HET is an N-linked 5-membered heteroaryl ring, optionally substituted on a C atom by an oxo or thioxo group; and/or by 1 or 2 (1-4C)alkyl groups; and/or on an available nitrogen atom by (1-4C)alkyl; or HET is an N-linked 6-membered heteroaryl ring containing up to three nitrogen heteroatoms in total, optionally substituted on a C atom as above;
Q is selected from, for example, Q1
2
R
2
and R
3
are independently hydrogen or fluoro;
T is selected from a range of groups, for example, of formula (TC
5
)
3
wherein Rc is, for example, R
13
CO—, R
13
SO
2
— or R
13
CS—;
wherein R
13
is, for example, optionally substituted (1-10C)alkyl or R
14
C(O)O(1-6C)alkyl wherein R
14
is optionally substituted (1-10C)alkyl; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
式(I)化合物,或其药学上可接受的盐,或其体内可水解的酯,其中HET为N-连接的5元杂环芳基环,可在碳原子上被氧或硫氧化物基替代;和/或由1或2个(1-4C)烷基基团替代;和/或在可用的氮原子上由(1-4C)烷基替代;或HET为含有总共高达三个氮杂原子的N-连接的6元杂环芳基环,可在碳原子上如上所述替代;Q选自,例如,Q12R2和R3独立地为氢或氟;T选自一系列基团,例如,公式(TC5)3,其中Rc为例如R13CO—,R13SO2—或R13CS—;其中R13为例如可选择的(1-10C)烷基或R14C(O)O(1-6C)烷基,其中R14为可选择的(1-10C)烷基;它们是抗菌剂;并描述了它们的制造过程和含有它们的药物组合物。